Latest News from: Wistar Institute

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 280
Newswise: Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Article ID: 721150

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Wistar Institute

The American Cancer Society has awarded a Research Professorship to Wistar's Dmitry l. Gabrilovich, M.D., Ph.D. This lifelong designation, accompanied by a five-year $400,000 commitment, is the most prestigious research grant made by ACS.

Released:
22-Oct-2019 10:30 AM EDT

Announcement

Channels:

Cancer,

Languages:

English

Newswise: $12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Article ID: 720921

$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Wistar Institute

Wistar and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.

Released:
17-Oct-2019 9:40 AM EDT
Newswise: New Mechanism Fueling Brain Metastasis Discovered at Wistar

Article ID: 720445

New Mechanism Fueling Brain Metastasis Discovered at Wistar

Wistar Institute

Wistar scientists described a novel mechanism through which astrocytes, the most abundant supporting cells in the brain, also promote cancer cell growth and metastasis in the brain.

Released:
9-Oct-2019 11:05 AM EDT

Research Results

Channels:

Cancer, All Journal News,

Languages:

English

Newswise: Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies
  • Embargo expired:
    3-Oct-2019 10:00 AM EDT

Article ID: 720048

Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies

Wistar Institute

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

Released:
2-Oct-2019 3:05 PM EDT
Newswise: NIH New Innovator Award Given to Wistar Researcher to Unravel the Metabolic Link Between Diet, Alcohol Consumption and Cancer
  • Embargo expired:
    1-Oct-2019 10:00 AM EDT

Article ID: 719893

NIH New Innovator Award Given to Wistar Researcher to Unravel the Metabolic Link Between Diet, Alcohol Consumption and Cancer

Wistar Institute

The National Institutes of Health (NIH) today announced that Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at Wistar, was awarded the prestigious NIH Director’s New Innovator Award in support of his research on the link between a high sugar/fat diet, alcohol use and cancer.

Released:
1-Oct-2019 9:40 AM EDT
Newswise: Wistar Receives More than $12 Million to Fund 
Innovative Clinical Research on the Impact of Opioid Use on Response to Therapy in People Living with HIV

Article ID: 719510

Wistar Receives More than $12 Million to Fund Innovative Clinical Research on the Impact of Opioid Use on Response to Therapy in People Living with HIV

Wistar Institute

Wistar was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar’s HIV Research Program.

Released:
24-Sep-2019 10:05 AM EDT
Newswise: Identification of a Novel Regulator of Mitochondrial Cell Death Reveals a Promising Target for Cancer Therapy

Article ID: 719254

Identification of a Novel Regulator of Mitochondrial Cell Death Reveals a Promising Target for Cancer Therapy

Wistar Institute

Wistar researchers have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target.

Released:
19-Sep-2019 9:00 AM EDT
Newswise: Major Grant Awarded to Wistar Supports Development of a Novel Therapeutic Approach for Antibiotic-resistant Bacteria

Article ID: 718933

Major Grant Awarded to Wistar Supports Development of a Novel Therapeutic Approach for Antibiotic-resistant Bacteria

Wistar Institute

Wistar has received a grant of approximately $4.6 million from the National Institutes of Health in support of innovative research to tackle antibiotic resistance.

Released:
12-Sep-2019 3:05 PM EDT
Newswise: Repeated Semen Exposure Promotes Host Resistance to Infection in Preclinical Model of HIV
  • Embargo expired:
    21-Aug-2019 5:00 AM EDT

Article ID: 717752

Repeated Semen Exposure Promotes Host Resistance to Infection in Preclinical Model of HIV

Wistar Institute

Contrary to the long-held view that semen can only act as a way to transmit HIV-1 from men to women, scientists at The Wistar Institute and the University of Puerto Rico found that frequent and sustained semen exposure can change the characteristics of the circulating and vaginal tissue immune cells that are targets for infection, reducing the susceptibility to a future infection.

Released:
20-Aug-2019 4:05 PM EDT
Wis_Square_logo_color.png

Article ID: 713341

Novel Role in Spatial Chromosome Organization Identified for Frequently Mutated Cancer Protein

Wistar Institute

New research from The Wistar Institute sheds light on the function of the ARID1A protein, encoded by a gene that is among the most frequently mutated across human cancers.

Released:
22-May-2019 2:05 PM EDT

Showing results

110 of 280

Chat now!